These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3619161)

  • 21. The comparative efficacy of various multiple-dose activated charcoal regimens.
    Ilkhanipour K; Yealy DM; Krenzelok EP
    Am J Emerg Med; 1992 Jul; 10(4):298-300. PubMed ID: 1616516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Model for theophylline overdose treatment with oral activated charcoal.
    Radomski L; Park GD; Goldberg MJ; Spector R; Johnson GF; Quee CK
    Clin Pharmacol Ther; 1984 Mar; 35(3):402-8. PubMed ID: 6697647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow-release theophylline.
    Goldberg MJ; Spector R; Park GD; Johnson GF; Roberts P
    Clin Pharmacol Ther; 1987 Jan; 41(1):108-11. PubMed ID: 3802699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A ready-to-use activated charcoal mixture. Adsorption studies in vitro and in dogs: its influence on the intestinal secretion of theophylline in a rat model.
    Rademaker CM; van Dijk A; de Vries MH; Kadir F; Glerum JH
    Pharm Weekbl Sci; 1989 Apr; 11(2):56-60. PubMed ID: 2726418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic modelling of the effect of activated charcoal on the intestinal secretion of theophylline, using the isolated vascularly perfused rat small intestine.
    de Vries MH; Rademaker CM; Geerlings C; Van Dijk A; Noordhoek J
    J Pharm Pharmacol; 1989 Aug; 41(8):528-33. PubMed ID: 2571696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of extracorporeal drug removal in acute theophylline poisoning. A review.
    Heath A; Knudsen K
    Med Toxicol Adverse Drug Exp; 1987; 2(4):294-308. PubMed ID: 3306269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport of theophylline from blood to the intestinal lumen following i.v. administration to rats.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1985 Apr; 8(4):324-7. PubMed ID: 4032222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Theophylline poisoning in childhood: depurative therapy using a combination of activated charcoal and a saline cathartic].
    Chiossi M; Rosati U; Renna S; Lattere M; De Santis L
    Minerva Pediatr; 1989 Oct; 41(10):535-7. PubMed ID: 2615728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceleration of the body clearance of phenobarbital by oral activated charcoal.
    Berg MJ; Berlinger WG; Goldberg MJ; Spector R; Johnson GF
    N Engl J Med; 1982 Sep; 307(11):642-4. PubMed ID: 7050705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent haemodialysis and sustained low-efficiency dialysis (SLED) for acute theophylline toxicity.
    Fisher J; Graudins A
    J Med Toxicol; 2015 Sep; 11(3):359-63. PubMed ID: 25794556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of theophylline overdoses and toxicities.
    Paloucek FP; Rodvold KA
    Ann Emerg Med; 1988 Feb; 17(2):135-44. PubMed ID: 3276248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of phenytoin elimination by multiple-dose activated charcoal.
    Mauro LS; Mauro VF; Brown DL; Somani P
    Ann Emerg Med; 1987 Oct; 16(10):1132-5. PubMed ID: 3662159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Increase in the clearance of theophylline with activated carbon].
    Mangues MA; Pérez C; Castellano A; Bonal J
    Med Clin (Barc); 1986 Sep; 87(7):306. PubMed ID: 3762259
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristics of vomiting associated with acute sustained release theophylline poisoning: implications for management with oral activated charcoal.
    Amitai Y; Lovejoy FH
    J Toxicol Clin Toxicol; 1987; 25(7):539-54. PubMed ID: 2895817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of gastric emptying and charcoal administration in fatal sustained-release theophylline overdose: pharmacobezoar formation.
    Bernstein G; Jehle D; Bernaski E; Braen GR
    Ann Emerg Med; 1992 Nov; 21(11):1388-90. PubMed ID: 1416337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged toxicity following massive ingestion of sustained-release theophylline preparation.
    Corser BC; Youngs C; Baughman RP
    Chest; 1985 Nov; 88(5):749-50. PubMed ID: 4053717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of activated charcoal on the pharmacokinetics of high-dose methotrexate.
    Gadgil SD; Damle SR; Advani SH; Vaidya AB
    Cancer Treat Rep; 1982 May; 66(5):1169-71. PubMed ID: 7083219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnesium toxicity secondary to catharsis during management of theophylline poisoning.
    Garrelts JC; Watson WA; Holloway KD; Sweet DE
    Am J Emerg Med; 1989 Jan; 7(1):34-7. PubMed ID: 2914046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theophylline poisoning. Pharmacological considerations and clinical management.
    Gaudreault P; Guay J
    Med Toxicol; 1986; 1(3):169-91. PubMed ID: 3537617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sorbitol, single, and multidose activated charcoal administration on carprofen absorption following experimental overdose in dogs.
    Koenigshof AM; Beal MW; Poppenga RH; Jutkowitz LA
    J Vet Emerg Crit Care (San Antonio); 2015; 25(5):606-10. PubMed ID: 25891141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.